Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 6, 2023
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
Timur Ivannikov Downgraded (ANAB) to Hold on, Jan 6th, 2023
Timur Ivannikov of Raymond James, Downgraded "AnaptysBio, Inc." (ANAB) to Hold on, Jan 6th, 2023.
Timur has made no other calls on ANAB in the last 4 months.
There are 5 other peers that have a rating on ANAB. Out of the 5 peers that are also analyzing ANAB, 1 agrees with Timur's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Lee of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Tuesday, September 13th, 2022
These are the ratings of the 4 analyists that currently disagree with Timur
- Anupam Rama of "JP Morgan" Maintained at Sell with Increased Target to $32 on, Friday, November 18th, 2022
- Steven Seedhouse of "Raymond James" Maintained at Buy with Increased Target to $38 on, Wednesday, November 9th, 2022
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy on, Tuesday, November 1st, 2022
- Gobind Singh of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Monday, September 19th, 2022
